'Seronegative' myasthenia gravis is no longer seronegative

Brain

Volumn 131, Issue 7, 2008, Pages 1684-1685

  Lindstrom, Jon ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN I 125; AUTOANTIBODY; CHOLINERGIC RECEPTOR; RAPSYN;

BINDING SITE; CYTOSKELETON; GENETIC TRANSFECTION; HUMAN; IMMUNOASSAY; IMMUNOPRECIPITATION; ISOTOPE LABELING; KIDNEY CELL; MYASTHENIA GRAVIS; NEUROMUSCULAR TRANSMISSION; NONHUMAN; NOTE; PRIORITY JOURNAL; SEROLOGY;

AUTOANTIBODIES; FALSE NEGATIVE REACTIONS; HUMANS; IMMUNOGLOBULIN G; MICROSCOPY, FLUORESCENCE; MYASTHENIA GRAVIS; RECEPTORS, CHOLINERGIC;

EID: 46849108511     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn131     Document Type: Note

References (14)

1. Barrett-Jolley R, Byrne N, Vincent A, Newsom-Davies J. Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line. Pflugers Arch 1994; 428: 492-8.
2. Bufler J, Pitz R, Czep M, Wick M, Franke C. Purified IgG from seropositive and seronegative patients with mysasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels. Ann Neurol 1998; 43: 458-64.
3. Engel A, Hohlfeld R. Acquired autoimmune myasthenia gravis. In: Engel A, Franzini-Armstrong C, editors. Myology. 3rd edn. New York: McGraw-Hill; 2004. p. 1755-90.
4. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001; 7: 365-8.
5. Kalamida D, Poulas K, Avramopoulou V, Fostieri E, Lagoumintzis G, Lazaridis K, et al. Muscle and neuronal nicotinic acetylcholine receptors. Structure, function and pathogenicity. FEBS J. 2007; 274: 3799-845.
6. Kuryatov A, Luo J, Cooper J, Lindstrom J. Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors. Mol Pharmacol 2005; 68: 1839-51.
7. Lindstrom J. Acetylcholine receptors and myasthenia. Muscle Nerve 2000; 23: 453-77.
8. Lindstrom J, Einarson B, Lennon V, Seybold M. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. J Exp Med 1976a; 144: 726-38.
9. Lindstrom J, Luo J, Kuryatov A. MG and the tops and bottoms of AChRs. Ann NY Acad Sci. 2008; in press.
10. Lindstrom J, Seybold M, Lennon V, Whittingham S, Duane D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 1976b; 26: 1054-9.
11. Patrick J, Lindstrom J. Autoimmune response to acetylcholine receptor. Science 1973; 180: 871-2.
12. Vincent A, Lang B, Kleopa K. Autoimmune channelopathies and related neurological disorders. Neuron 2006; 52: 123-38.
13. Vincent A, Leite M. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol 2005; 18: 519-25.
14. Yamamoto T, Vincent A, Ciulla TA, Lang B, Johnston I, Newsom-Davis J. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM. Ann Neurol 1991; 30: 550-7.